Skip to content

Utility of CC7 Transfer in Stroke Subtypes

Seventh Cervical Nerve Transfer for Spastic Arm Paresis: A Prospective Analysis of Efficacy in Ischemic vs. Hemorrhagic Stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06001736
Enrollment
95
Registered
2023-08-21
Start date
2022-03-13
Completion date
2027-03-01
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spastic Hemiparesis, Stroke Hemorrhagic, Stroke, Ischemic

Keywords

Ischemic stroke, Hemorrhagic stroke, Spastic hemiparesis

Brief summary

The purpose of this study is to evaluate the limb functional improvement after contralateral C7 root transfer in stroke patients.

Detailed description

Spastic limb paresis after stroke is a cause of long-term disability and reduction is quality of life, with loss of hand dexterity being especially prohibitive. In the recovery phase after initial injury, neural reorganization occurs and has been observed in both ipsilateral and contralateral hemispheres. Previous studies have identified contralesional (opposite to the side of the injury), in other words, ipsilateral, activation in the recovery of paretic hand function. However, this pathway of recovery is limited due to sparse connections between the ipsilateral hemisphere and the affected arm/hand. By establishing an anatomic connection between the ipsilateral hemisphere and the paretic arm with contralateral nerve transfer, compensatory capacity of the ipsilateral hemisphere is facilitated. This cross neck C7-C7 root transfer is an established procedure for the treatment of brachial plexus injuries and recently, for the treatment of spastic arm paresis in those with cerebral injury.

Interventions

PROCEDUREContralateral C7 root transfer for the treatment of spastic hemiparesis.

Performing surgery to transfer the C7 nerve to treat stroke patients experiencing spastic hemiparesis.

Sponsors

Dartmouth-Hitchcock Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* History of ischemic or hemorrhagic stroke with resultant arm paresis that has ceased to improve within 1-5 years of rehabilitation. * baseline Fugl-Meyer score below 33

Exclusion criteria

* pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in arm function, as measured by the Fugl-Meyer upper-extremity scale.12 months with visits at baseline and months 2, 4, 8, and 12 months after surgery.The Fugl-Meyer is a widely used and highly recommended stroke-specific, performance-based measure of impairment with 5 domains and a possible 226 points.

Countries

United States

Contacts

CONTACTLauren Sinks
Lauren.J.Sinks@hitchcock.org(603) 653-9021
PRINCIPAL_INVESTIGATORJennifer Hong, Dr.

Dartmouth-Hitchcock Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026